Innovations in SLE: Advancing Strategies for Promoting Equality in Care

In this interactive, CME-certified video module, Anca D. Askanase, MD, MPH; David R. Fernandez, MD, PhD; and Jane E. Salmon, MD, provide expert perspectives on SLE diagnosis and management and discuss emerging therapeutics, with a focus on women of color.
Anca D. Askanase, MD, MPH
David R. Fernandez, MD, PhD
Chaim Putterman, MD
Jane E. Salmon, MD
Physicians: maximum of 1.25 AMA PRA Category 1 Credits
Released: March 13, 2018 Expiration: April 22, 2019
Multimedia Innovations in SLE: Advancing Strategies for Promoting Equality in Care
This program is divided into short segments. After reviewing all segments, click the Claim Credit button to complete the CME posttest and evaluation.
Diagnosis, Pathophysiology, and Emerging Therapeutic Targets in SLE (38 mins)
Anca D. Askanase, MD, MPH; David R. Fernandez, MD, PhD; and Jane E. Salmon, MD, provide expert perspectives on SLE diagnosis and discuss potential therapeutic targets in the context of SLE pathophysiology, with a focus on women of color.
Launch Diagnosis, Pathophysiology, and Emerging Therapeutic Targets in SLE (38 mins)
Current Best Practices and Emerging Therapeutic Strategies in SLE Management (30 mins)
Anca D. Askanase, MD, MPH; David R. Fernandez, MD, PhD; and Jane E. Salmon, MD, discuss optimal management of patients with SLE and provide expert perspectives on emerging investigational agents.
Launch Current Best Practices and Emerging Therapeutic Strategies in SLE Management (30 mins)

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Consider SLE in the differential diagnosis in women of color who present with suggestive symptoms and perform appropriate workup to confirm a diagnosis to promptly initiate treatment
  • Develop effective SLE management teams for underserved patients who have limited healthcare resources to improve outcomes in this vulnerable population
  • Explore emerging data from key clinical trials on new therapies and biomarkers for SLE and their significance in minority patient populations while implementing strategies to encourage minority participation in SLE-focused clinical trials

Acknowledgements

Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
PIM Logo

Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112

Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)
ahughes@pimed.com
www.pimed.com

Supported by educational grants from
AstraZeneca Pharmaceuticals LP
GlaxoSmithKline

Information on this Educational Activity

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Faculty

Anca D. Askanase, MD, MPH

Associate Professor of Medicine
Division of Rheumatology
Director, Lupus Center
Columbia University Medical Center
New York, New York

Anca D. Askanase, MD, MPH, has no real or apparent conflicts of interest to report.

David R. Fernandez, MD, PhD

Assistant Attending Physician
Department of Rheumatology
Hospital for Special Surgery
New York, New York

David R. Fernandez, MD, PhD, has no real or apparent conflicts of interest to report.

Chaim Putterman, MD

Professor of Medicine, Microbiology and Immunology
Chief of Rheumatology
Albert Einstein College of Medicine
Bronx, New York

Chaim Putterman, MD, has no real or apparent conflicts of interest to report.

Jane E. Salmon, MD

Professor 
Division of Rheumatology
Department of Medicine
Hospital for Special Surgery
Weill Cornell College of Medicine
New York, New York

Jane E. Salmon, MD, has no real or apparent conflicts of interest to report.

Staff

Megan K. Murphy, PhD

Scientific Director

Megan K. Murphy, PhD, has no real or apparent conflicts of interest to report.

Jenny Schulz, PhD

Director, Scientific Services

Jenny Schulz, PhD, has no real or apparent conflicts of interest to report.

Ryan P. Topping, PhD

Scientific Director

Ryan P. Topping, PhD, has no real or apparent conflicts of interest to report.

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

The following PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, RN, BSN and Jan Schultz, RN, MSN, CHCP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Target Audience

This program is intended for rheumatologists and other healthcare providers who care for patients with SLE.

Goal

The goal of this activity is to improve participants’ competence in applying current and emerging treatment strategies in the management of women of color with SLE.

Physician Continuing Medical Education


Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Clinical Care Options, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Program Medium

This program has been made available online.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1.25 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from March 13, 2018, through April 22, 2019:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?